The Lansing animal and food safety testing product maker Neogen Corp. (Nasdaq: NEOG) Tuesday announced net income of $6.6 million for for the third quarter of its fiscal year, which ended Feb. 28, down from $6.7 million in the same period a year earlier. Earnings per share was unchanged at 18 cents for both periods. Revenue for the quarter was $62 million, up 21 percent from $51.1 million a year earlier.
Some Michigan Humane Society staffers will be spending the night in doghouses this week, as part of an effort to raise awareness about the dangers of leaving pets outside in freezing temperatures.
Neogen Corp. (Nasdaq: NEOG) Wednesday announced that all shares of its common stock will begin trading today on a “post-split” basis to reflect the company’s previously announced 3-for-2 stock split.
Lansing-based Neogen Corp. announced that its net income for the third quarter of fiscal year 2013, which ended Feb. 28, increased 27 percent to $6.7 million or 27 cents a share, up from $5.2 million or 22 cents a share in the same quarter a year earlier.
The Lansing biotech firm Neogen Corp. (Nasdaq: NEOG) Tuesday announced fiscal fourth quarter revenue of $48.5 million, up 11 percent from $43.6 million a year earlier. The company’s fiscal year ended May 31.
Lansing-based Neogen Corp. Tuesday announced a 30 percent increase in net income for its fiscal year ended May 31, to $22.8 million or 96 cents a share, up from $17.5 million or 76 cents a share. Revenue for the fiscal year was up 23 percent to $172.7 million from $140.5 million in the prior fiscal year.
Neogen Corp., the Lansing-based biotech firm, reported a 27 percent increase in net income for the third fiscal quarter ended Feb. 28 from year-earlier levels — to $4.9 milllion or 21 cents a share, from $3.9 million or 17 cents a share a year earlier. Third quarter revenue rose 25 percent to $42.2 million, a record third quarter for the 28-year-old company.